Intelligence / Healthtech / New Clinical Trials / Dr. August Wolff GmbH & Co. KG Arzneimittel
Dr. August Wolff GmbH & Co. KG Arzneimittel
16 Nov 2026: Trial registered · Non-inferiority Study of a Hydroxyapatite and Calcium Hypophosphite Toothpaste Compared With Two Comparator Toothpastes in Dentin Hypersensitivity. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 16 Nov 2026
- Title
- Non-inferiority Study of a Hydroxyapatite and Calcium Hypophosphite Toothpaste Compared With Two Comparator Toothpastes in Dentin Hypersensitivity
- Conditions
- Dentin Hypersensitivity
- Phase
- Not applicable
- Study Type
- Interventional
- Status
- Recruiting
- Countries
- Brazil
- Country
- Brazil
- Reference
- NCT07939620
- Location
- Brazil
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Find the decision makers at Dr. August Wolff GmbH & Co. KG Arzneimittel
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Brazil
New Clinical Trials
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.